EGFR and non-small cell lung carcinoma: Enhancement of EGFR activation by IL-17A overexpression was also observed in other EGFR-mutant NSCLC cells, such as HCC827 cells, even though H1975 cells harbored double mutations of EGFR (L858R and T790M) (Figure S2).